Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-019564
Filing Date
2023-03-17
Accepted
2023-03-17 15:40:08
Documents
2
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6091
2 POA DOCUMENT poa.txt EX-24 2930
  Complete submission text file 0001209191-23-019564.txt   10461
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address
Allan Jonathan (Reporting) CIK: 0001966716 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 23742277